📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Attrition when providing antiretroviral treatment at CD4 counts >500cells/µL at three government clinics included in the HPTN 071 (PopART) trial in South Africa (2018)

First Author: Bock P

Attributed to: Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0195127

PubMed Identifier: 29672542

Publication URI: http://europepmc.org/abstract/MED/29672542

Type: Journal Article/Review

Parent Publication: PLOS ONE

Issue: 4

ISSN: 1932-6203